PUBLICATIONS | SURGICAL ONCOLOGY continued

Omission of Radiation in Conservative Treatment for Breast Cancer: Opportunity for De-escalation of Care.

Hong MJ, Lum SS, Dupont E, Howard-McNatt M, Chiba A, Levine EA, Gass JS, Gallagher K, Fenton A, Murray M, Solomon NL, Ollila DW, Lazar M, Namm JP, Walters LL, Chagpar AB; SHAVE2 Investigators. J Surg Res. 2022 Nov;279:393-397. doi: 10.1016/j. jss.2022.06.036. Epub 2022 Jul 11. PMID: 35835032

Can We Forgo Sentinel Lymph Node Biopsy in Women Aged ≥ 50 Years with Early-Stage Hormone-Receptor-Positive HER2Negative Special Histologic Subtype Breast Cancer?

Knape N, Park JH, Agala CB, Spanheimer P, Morrow M, DownsCanner S, Baldwin XL. Ann Surg Oncol. 2023 Feb;30(2):10421050. doi: 10.1245/s10434-022-12626-6. Epub 2022 Oct 10. PMID: 36217063

A Review of Immune Checkpoint Blockade for the General Surgeon.

Baldwin XL, Spanheimer PM, Downs-Canner S. J Surg Res. 2023 Jan;281:289-298. doi: 10.1016/j.jss.2022.08.040. Epub 2022 Oct 10. PMID: 36228339 Review.

Breast surgery after neoadjuvant chemotherapy: time for a change?

Spanheimer PM, Reeder-Hayes KE. Lancet Oncol. 2022 Dec;23(12):1477-1479. doi: 10.1016/S1470-2045(22)00649-0.

Epub 2022 Oct 25. PMID: 36306811 No abstract available.

ASO Author Reflections: Can Genomic Recurrence Score Replace SLNB in Postmenopausal Women with ER+/HER2- Breast Cancer?

Amlicke MJ, Spanheimer PM. Ann Surg Oncol. 2022 Nov;29(12):7670-7671. doi: 10.1245/s10434-022-12175-y. Epub 2022 Jul 13. PMID: 35831528 No abstract available.